Edwards Lifesciencesvs.Zimmer Biomet
EW vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Edwards Lifesciences is about 2.8× larger than Zimmer Biomet by market cap; Zimmer Biomet trades at the lower P/E (21.5 vs 47.9).
Side by side
| EW | ZBH | |
|---|---|---|
| Market cap | $48.2B | $17.4B |
| Price | $85.21 | $89.14 |
| Today | +1.2% | +0.3% |
| Return YTD | −1.2% | −1.2% |
| Return 1Y | +11.2% | −9.6% |
| Since June 26, 2026 | −6.1% | −4.3% |
| P/E | 47.9 | 21.5 |
| P/S | 7.4 | 2.0 |
| P/B | 4.5 | 1.4 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Edwards LifesciencesEW
Heart valves, delivered by catheter as with TAVR or implanted surgically.
Full EW profile →More EW & ZBH comparisons
Other head-to-heads in the Medtech & devices segment.
See where EW and ZBH sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →